Basics of Compounding: Standardization of Compounded Medications
Download in electronic PDF format for $75
Abstract: The feasibility of standardizing concentrations of compounded drug preparations to attempt to minimize adverse events of both nonsterile and sterile compounded preparations has been discussed. It is critical that a wide variety of opinions and potential “unintended consequences” be aired in the public before an issue like this is recommended to become a standard. In this article, we combine the thoughts and recommendations of many practicing compounding pharmacists from both community and hospital practice sites that have contributed to this topic through the International Journal of Pharmaceutical Compounding’s Compounders’ Network List, a complimentary listserve for our subscribers to share information; ask questions; and provide answers, comments, and opinions. We discuss the advantages, disadvantages, and unintended consequences of standardized concentrations and provide input from numerous practitioners who are “on the front lines” daily.
Related Keywords:
standardization of compounded preparations, standardized drug concentrations, parenteral drugs, intravenous drug admixtures, nonsterile pediatric drugs, drug safety, children, quality assurance, medication errors, hospital pharmacy, Compounders Network List
Related Categories:
LEGAL, PARENTERALS, PEDIATRICS, QUALITY CONTROL, ADVERSE DRUG EVENTS, HOSPITAL PHARMACY
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 35-44
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
May/Jun 2021
Pg. 222-229
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 396-400
|
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
|
Nov/Dec 2012
Pg. 456-460
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta, Bufarini Celestino
|
Sep/Oct 2014
Pg. 358-364
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
|
Sep/Oct 2021
Pg. 358-362
|
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
|
Jul/Aug 2022
Pg. 298-301
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Return to Top |